RVTY vs. TWST: A Head-to-Head Stock Comparison
Updated onHere’s a clear look at RVTY and TWST, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.
Company Profile
| Symbol | RVTY | TWST |
|---|---|---|
| Company Name | Revvity, Inc. | Twist Bioscience Corporation |
| Country | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry | Life Sciences Tools & Services | Biotechnology |
| Market Capitalization | 10.64 billion USD | 1.60 billion USD |
| Exchange | NYSE | NasdaqGS |
| Listing Date | February 21, 1973 | October 31, 2018 |
| Security Type | Common Stock | Common Stock |
Historical Performance
This chart compares the performance of RVTY and TWST by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.
Historical Performance at a Glance
| Symbol | RVTY | TWST |
|---|---|---|
| 5-Day Price Return | 2.52% | -8.29% |
| 13-Week Price Return | -2.76% | -12.96% |
| 26-Week Price Return | -18.76% | -43.57% |
| 52-Week Price Return | -23.74% | -40.41% |
| Month-to-Date Return | 4.32% | -21.21% |
| Year-to-Date Return | -17.84% | -43.08% |
| 10-Day Avg. Volume | 1.11M | 2.14M |
| 3-Month Avg. Volume | 1.31M | 1.29M |
| 3-Month Volatility | 36.53% | 58.53% |
| Beta | 0.99 | 2.39 |
Profitability
Return on Equity (TTM)
RVTY
3.71%
Life Sciences Tools & Services Industry
- Max
- 19.96%
- Q3
- 11.55%
- Median
- 6.22%
- Q1
- 3.86%
- Min
- -6.95%
RVTY’s Return on Equity of 3.71% is in the lower quartile for the Life Sciences Tools & Services industry. This indicates a less efficient generation of profit from its equity base when compared to its competitors.
TWST
-18.45%
Biotechnology Industry
- Max
- 77.14%
- Q3
- 10.76%
- Median
- -20.08%
- Q1
- -42.71%
- Min
- -119.20%
TWST has a negative Return on Equity of -18.45%. This indicates the company is generating a loss for its shareholders, which can be a result of unprofitability or negative shareholder equity and is often a sign of financial distress.
Net Profit Margin (TTM)
RVTY
10.19%
Life Sciences Tools & Services Industry
- Max
- 27.28%
- Q3
- 16.17%
- Median
- 7.24%
- Q1
- 3.00%
- Min
- -3.05%
RVTY’s Net Profit Margin of 10.19% is aligned with the median group of its peers in the Life Sciences Tools & Services industry. This indicates its ability to convert revenue into profit is typical for the sector.
TWST
-23.51%
Biotechnology Industry
- Max
- 59.44%
- Q3
- 16.21%
- Median
- -11.49%
- Q1
- -167.42%
- Min
- -409.07%
TWST has a negative Net Profit Margin of -23.51%, indicating the company is operating at a net loss as its expenses exceeded its revenues.
Operating Profit Margin (TTM)
RVTY
13.57%
Life Sciences Tools & Services Industry
- Max
- 33.15%
- Q3
- 19.34%
- Median
- 13.02%
- Q1
- 8.05%
- Min
- -4.38%
RVTY’s Operating Profit Margin of 13.57% is around the midpoint for the Life Sciences Tools & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.
TWST
-39.30%
Biotechnology Industry
- Max
- 60.62%
- Q3
- 20.76%
- Median
- -12.41%
- Q1
- -181.14%
- Min
- -482.02%
TWST has a negative Operating Profit Margin of -39.30%. This signifies the company is unprofitable at the operational level, as its core business expenses exceed its revenue.
Profitability at a Glance
| Symbol | RVTY | TWST |
|---|---|---|
| Return on Equity (TTM) | 3.71% | -18.45% |
| Return on Assets (TTM) | 2.29% | -13.84% |
| Net Profit Margin (TTM) | 10.19% | -23.51% |
| Operating Profit Margin (TTM) | 13.57% | -39.30% |
| Gross Profit Margin (TTM) | 55.93% | 49.24% |
Financial Strength
Current Ratio (MRQ)
RVTY
3.33
Life Sciences Tools & Services Industry
- Max
- 4.76
- Q3
- 2.77
- Median
- 1.85
- Q1
- 1.40
- Min
- 0.43
RVTY’s Current Ratio of 3.33 is in the upper quartile for the Life Sciences Tools & Services industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.
TWST
3.90
Biotechnology Industry
- Max
- 19.31
- Q3
- 9.38
- Median
- 4.54
- Q1
- 2.45
- Min
- 0.76
TWST’s Current Ratio of 3.90 aligns with the median group of the Biotechnology industry, indicating that its short-term liquidity is in line with its sector peers.
Debt-to-Equity Ratio (MRQ)
RVTY
0.43
Life Sciences Tools & Services Industry
- Max
- 1.75
- Q3
- 0.83
- Median
- 0.41
- Q1
- 0.18
- Min
- 0.00
RVTY’s Debt-to-Equity Ratio of 0.43 is typical for the Life Sciences Tools & Services industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
TWST
0.00
Biotechnology Industry
- Max
- 1.35
- Q3
- 0.64
- Median
- 0.09
- Q1
- 0.00
- Min
- 0.00
TWST’s Debt-to-Equity Ratio of 0.00 is typical for the Biotechnology industry, indicating its use of leverage is in line with the sector norm. This suggests a balanced approach to its capital structure.
Interest Coverage Ratio (TTM)
RVTY
15.30
Life Sciences Tools & Services Industry
- Max
- 29.61
- Q3
- 23.24
- Median
- 6.07
- Q1
- 2.18
- Min
- -14.08
RVTY’s Interest Coverage Ratio of 15.30 is positioned comfortably within the norm for the Life Sciences Tools & Services industry, indicating a standard and healthy capacity to cover its interest payments.
TWST
-235.67
Biotechnology Industry
- Max
- 72.37
- Q3
- 1.91
- Median
- -7.81
- Q1
- -63.90
- Min
- -153.80
TWST has a negative Interest Coverage Ratio of -235.67. This indicates that its earnings were insufficient to cover even its operational costs, let alone its interest payments, signaling significant financial distress.
Financial Strength at a Glance
| Symbol | RVTY | TWST |
|---|---|---|
| Current Ratio (MRQ) | 3.33 | 3.90 |
| Quick Ratio (MRQ) | 2.75 | 3.45 |
| Debt-to-Equity Ratio (MRQ) | 0.43 | 0.00 |
| Interest Coverage Ratio (TTM) | 15.30 | -235.67 |
Growth
Revenue Growth
EPS Growth
Dividend
Dividend Yield (TTM)
RVTY
0.32%
Life Sciences Tools & Services Industry
- Max
- 1.80%
- Q3
- 0.78%
- Median
- 0.37%
- Q1
- 0.00%
- Min
- 0.00%
RVTY’s Dividend Yield of 0.32% is consistent with its peers in the Life Sciences Tools & Services industry, providing a dividend return that is standard for its sector.
TWST
0.00%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
TWST currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.
Dividend Payout Ratio (TTM)
RVTY
11.88%
Life Sciences Tools & Services Industry
- Max
- 156.00%
- Q3
- 65.73%
- Median
- 23.81%
- Q1
- 0.00%
- Min
- 0.00%
RVTY’s Dividend Payout Ratio of 11.88% is within the typical range for the Life Sciences Tools & Services industry, suggesting a balanced approach between shareholder payouts and company reinvestment.
TWST
0.00%
Biotechnology Industry
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
TWST has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.
Dividend at a Glance
| Symbol | RVTY | TWST |
|---|---|---|
| Dividend Yield (TTM) | 0.32% | 0.00% |
| Dividend Payout Ratio (TTM) | 11.88% | 0.00% |
Valuation
Price-to-Earnings Ratio (TTM)
RVTY
37.17
Life Sciences Tools & Services Industry
- Max
- 117.96
- Q3
- 65.59
- Median
- 37.26
- Q1
- 27.51
- Min
- 1.73
RVTY’s P/E Ratio of 37.17 is within the middle range for the Life Sciences Tools & Services industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.
TWST
--
Biotechnology Industry
- Max
- 60.14
- Q3
- 38.17
- Median
- 29.01
- Q1
- 15.12
- Min
- 0.00
P/E Ratio data for TWST is currently unavailable.
Price-to-Sales Ratio (TTM)
RVTY
3.79
Life Sciences Tools & Services Industry
- Max
- 12.46
- Q3
- 6.70
- Median
- 4.24
- Q1
- 2.68
- Min
- 0.73
RVTY’s P/S Ratio of 3.79 aligns with the market consensus for the Life Sciences Tools & Services industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.
TWST
4.39
Biotechnology Industry
- Max
- 76.98
- Q3
- 36.53
- Median
- 9.49
- Q1
- 4.49
- Min
- 0.00
In the lower quartile for the Biotechnology industry, TWST’s P/S Ratio of 4.39 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.
Price-to-Book Ratio (MRQ)
RVTY
1.51
Life Sciences Tools & Services Industry
- Max
- 7.99
- Q3
- 4.69
- Median
- 3.30
- Q1
- 1.88
- Min
- 1.02
RVTY’s P/B Ratio of 1.51 is in the lower quartile for the Life Sciences Tools & Services industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.
TWST
4.61
Biotechnology Industry
- Max
- 20.53
- Q3
- 9.76
- Median
- 4.77
- Q1
- 2.49
- Min
- 0.59
TWST’s P/B Ratio of 4.61 is within the conventional range for the Biotechnology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.
Valuation at a Glance
| Symbol | RVTY | TWST |
|---|---|---|
| Price-to-Earnings Ratio (TTM) | 37.17 | -- |
| Price-to-Sales Ratio (TTM) | 3.79 | 4.39 |
| Price-to-Book Ratio (MRQ) | 1.51 | 4.61 |
| Price-to-Free Cash Flow Ratio (TTM) | 21.07 | -- |